Multi-scale Monte Carlo simulations of gold nanoparticle-induced DNA damages for kilovoltage X-ray irradiation in a xenograft mouse model using TOPAS-nBio.


Journal

Cancer nanotechnology
ISSN: 1868-6958
Titre abrégé: Cancer Nanotechnol
Pays: Austria
ID NLM: 101516978

Informations de publication

Date de publication:
2021
Historique:
entrez: 6 6 2022
pubmed: 1 1 2021
medline: 1 1 2021
Statut: ppublish

Résumé

Gold nanoparticles (AuNPs) are considered as promising agents to increase the radiosensitivity of tumor cells. However, the biological mechanisms of radiation enhancement effects of AuNPs are still not well understood. We present a multi-scale Monte Carlo simulation framework within TOPAS-nBio to investigate the increase of DNA damage due to the presence of AuNPs in mouse tumor models. A tumor was placed inside a voxel mouse model and irradiated with either 100 kVp or 200 kVp x-ray beams. Phase spaces were employed to transfer particles from the macroscopic (voxel) scale to the microscopic scale, which consists of a cell geometry including a detailed mouse DNA model. Radiosensitizing effects were calculated in the presence and absence of hybrid nanoparticles with a Fe2O3 core surrounded by a gold layer (AuFeNPs). To simulate DNA damage even for very small energy tracks, Geant4-DNA physics and chemistry models were used on microscopic scale. An AuFeNP induced enhancement of both dose and DNA strand breaks has been established for different scenarios. Produced chemical radicals including hydroxyl molecules, which were assumed to be responsible for DNA damage through chemical reactions, were found to be significantly increased. We further observed a dependency of the results on the location of the cells within the tumor for 200 kVp x-ray beams. Our multi-scale approach allows to study irradiation induced physical and chemical effects on cells. We showed a potential increase in cell radiosensitization caused by relatively small concentrations of AuFeNPs. Our new methodology allows the individual adjustment of parameters in each simulation step and therefore can be used for other studies investigating the radiosensitizing effects of AuFeNPs or AuNPs in living cells.

Sections du résumé

Background UNASSIGNED
Gold nanoparticles (AuNPs) are considered as promising agents to increase the radiosensitivity of tumor cells. However, the biological mechanisms of radiation enhancement effects of AuNPs are still not well understood. We present a multi-scale Monte Carlo simulation framework within TOPAS-nBio to investigate the increase of DNA damage due to the presence of AuNPs in mouse tumor models.
Methods UNASSIGNED
A tumor was placed inside a voxel mouse model and irradiated with either 100 kVp or 200 kVp x-ray beams. Phase spaces were employed to transfer particles from the macroscopic (voxel) scale to the microscopic scale, which consists of a cell geometry including a detailed mouse DNA model. Radiosensitizing effects were calculated in the presence and absence of hybrid nanoparticles with a Fe2O3 core surrounded by a gold layer (AuFeNPs). To simulate DNA damage even for very small energy tracks, Geant4-DNA physics and chemistry models were used on microscopic scale.
Results UNASSIGNED
An AuFeNP induced enhancement of both dose and DNA strand breaks has been established for different scenarios. Produced chemical radicals including hydroxyl molecules, which were assumed to be responsible for DNA damage through chemical reactions, were found to be significantly increased. We further observed a dependency of the results on the location of the cells within the tumor for 200 kVp x-ray beams.
Conclusions UNASSIGNED
Our multi-scale approach allows to study irradiation induced physical and chemical effects on cells. We showed a potential increase in cell radiosensitization caused by relatively small concentrations of AuFeNPs. Our new methodology allows the individual adjustment of parameters in each simulation step and therefore can be used for other studies investigating the radiosensitizing effects of AuFeNPs or AuNPs in living cells.

Identifiants

pubmed: 35663252
doi: 10.1186/s12645-021-00099-3
pmc: PMC9165761
mid: NIHMS1757385
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : R01 CA187003
Pays : United States

Références

Cancer Biol Med. 2017 Aug;14(3):228-241
pubmed: 28884040
Biochim Biophys Acta. 2010 Jan;1805(1):105-17
pubmed: 19931353
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1591-9
pubmed: 18640502
Phys Med Biol. 2016 Nov 7;61(21):7522-7535
pubmed: 27716643
Med Phys. 2011 Aug;38(8):4531-4
pubmed: 21928623
Radiat Res. 2019 Feb;191(2):125-138
pubmed: 30609382
Oncotarget. 2016 Dec 13;7(50):82889-82901
pubmed: 27756881
Chem Commun (Camb). 2014 Sep 21;50(73):10687-90
pubmed: 25078326
Chem Soc Rev. 2017 Jun 21;46(12):3830-3852
pubmed: 28516983
Phys Med Biol. 2018 Jan 09;63(2):02TR01
pubmed: 29125831
Phys Med. 2020 Jan;69:147-163
pubmed: 31918367
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):189-205
pubmed: 26700713
Science. 2009 Oct 9;326(5950):289-93
pubmed: 19815776
Med Phys. 2018 May;45(5):2230-2242
pubmed: 29480947
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9738-43
pubmed: 9707545
Phys Med Biol. 2015 Aug 21;60(16):6195-212
pubmed: 26226203
Nanotechnology. 2011 Nov 18;22(46):465101
pubmed: 22024607
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2
pubmed: 18432775
Radiother Oncol. 2011 Sep;100(3):412-6
pubmed: 21924786
Exp Cell Res. 1999 Apr 10;248(1):10-7
pubmed: 10094808
Phys Med Biol. 2018 May 17;63(10):105014
pubmed: 29697057
Small. 2009 Sep;5(18):2067-76
pubmed: 19642089
Med Phys. 2018 Jun 14;:
pubmed: 29901835
Sci Rep. 2017 Oct 16;7(1):13268
pubmed: 29038517
Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Jun;87(6):060701
pubmed: 23848615
Phys Med Biol. 2014 Dec 21;59(24):7675-89
pubmed: 25415297
Phys Med Biol. 2013 Jan 7;58(1):169-82
pubmed: 23221270
Med Phys. 2012 Nov;39(11):6818-37
pubmed: 23127075
Radiat Res. 2020 Jul 8;194(1):9-21
pubmed: 32401689
Sci Rep. 2017 Sep 20;7(1):11923
pubmed: 28931851
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
N Engl J Med. 2010 Nov 11;363(20):1938-48
pubmed: 21067385
J Am Chem Soc. 2012 Feb 1;134(4):1950-3
pubmed: 22260210
Radiat Oncol. 2019 May 30;14(1):88
pubmed: 31146751
IEEE Trans Med Imaging. 2004 Jun;23(6):764-71
pubmed: 15191150
Radiat Environ Biophys. 1999 Dec;38(4):229-37
pubmed: 10654344
Small. 2014 Aug 27;10(16):3338-46
pubmed: 24863679
Radiat Res. 2019 Jan;191(1):76-92
pubmed: 30407901
Phys Med. 2019 Jun;62:152-157
pubmed: 31109825
Phys Med Biol. 2018 Jun 25;63(13):135001
pubmed: 29873303
Chem Rev. 2016 Mar 9;116(5):2826-85
pubmed: 26799741
Cancer Nanotechnol. 2017;8(1):2
pubmed: 28217176
Phys Med. 2018 Apr;48:135-145
pubmed: 29628360
Phys Med Biol. 2020 Apr 23;65(8):085015
pubmed: 32101803
Phys Med Biol. 2018 Sep 06;63(17):175018
pubmed: 30088810
Phys Med Biol. 2019 Aug 07;64(15):155016
pubmed: 31300616
Phys Med Biol. 2019 Aug 28;64(17):175005
pubmed: 31295730
Nanoscale. 2017 May 11;9(18):5843-5853
pubmed: 28429022
Pharmaceutics. 2020 Jul 25;12(8):
pubmed: 32722426
Int J Radiat Biol. 2017 Nov;93(11):1239-1247
pubmed: 28752783
Phys Med Biol. 2009 Oct 7;54(19):N433-8
pubmed: 19724100

Auteurs

Alexander P Klapproth (AP)

Center for Translational Cancer Research Technische Universität München (TranslaTUM), Klinikum rechts der Isar, München, Germany.
Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.

Jan Schuemann (J)

Physics Division, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, United States of America.
Harvard Medical School, Boston, MA 02115, United States of America.

Stefan Stangl (S)

Center for Translational Cancer Research Technische Universität München (TranslaTUM), Klinikum rechts der Isar, München, Germany.

Tianwu Xie (T)

Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland.
Institute of Radiation Medicine, Fudan University, Shanghai, China.

Wei Bo Li (WB)

Institute of Radiation Medicine, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Neuherberg, Germany.

Gabriele Multhoff (G)

Center for Translational Cancer Research Technische Universität München (TranslaTUM), Klinikum rechts der Isar, München, Germany.

Classifications MeSH